Subscribe
Logo small
Search

Dorota Korycinska: Failure to use molecular diagnostics is a loss for patients and more costs for the system

MedExpress Team

Piotr Wójcik

Published Feb. 29, 2024 12:25

Dorota Korycinska: Failure to use molecular diagnostics is a loss for patients and more costs for the system - Header image
An interview with Dorota Korycinska, CEO of the National Federation of Oncology.

What is the patients' perspective on the ongoing work at the Ministry of Health to introduce molecular-based oncology diagnostics into the basket of guaranteed services?

Last fall, the National Federation of Oncology submitted an appeal to the Ministry of Health to support the efforts of the Polish Society of Oncology...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also